Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $67,830 - $98,510
500 Added 5.0%
10,500 $1.61 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $1.18 Million - $2.1 Million
10,000 New
10,000 $1.8 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $2.75 Million - $4.15 Million
23,500 New
23,500 $3.36 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $1.51 Million - $3.29 Million
-6,800 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $883,388 - $1.6 Million
6,800 New
6,800 $1.6 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.